Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conference Coverage Conference Listing
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story
Subscribe
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
Spotlight -
  • Blogs
  • Breast Cancer Webinar Series
  • Cancer Horizons
  • Clinical Trial Corner
  • Heal®
  • Publications
  • Videos
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
    • Subscribe
Advertisement

Publication

Article

February 22, 2019

CURE

Winter 2019
Volume18
Issue 1

Findings Link Diet Soda With Reduced Risk of Colon Cancer Recurrence

Author(s):

Beth Fand Incollingo

A daily dose of diet soda may help protect survivors of colon cancer from disease recurrence and death.

A daily dose of diet soda may help protect survivors of colon cancer from disease recurrence and death.

Survivors of stage 3 colon cancer undergoing chemotherapy after sur­gery benefited from drinking artificially sweetened beverages, according to study results published in July 2018. Those who drank at least one 12-ounce serving a day had roughly half the risk of cancer recurrence or death compared with survivors who usually didn’t drink these beverag­es. Increased intake of artificially sweetened drinks was also associated with a statistically significant improvement in length of life.

Furthermore, replacing a daily 12-ounce serving of a sugary drink with an artificially sweetened one was associated with a 23 percent lower risk of cancer recurrence and mortality, Brendan J. Guercio, M.D., and col­leagues, reported in a paper in the journal PLOS ONE.

The study authors explored the potential connection between arti­ficially sweetened drinks and better health outcomes because they knew from previous findings that having an excess energy balance — related to, for instance, a sedentary lifestyle, diabetes or high intake of sugar-sweetened beverages — is associated with increased colon cancer recurrence and mortality. “We hypothesized that artificially sweetened beverage intake might reduce colon cancer recurrence by substituting for, and thereby reduc­ing, intake of high-calorie, sugar-sweetened alternatives,” they wrote.

The 1,108 survivors in the study reported their dietary and lifestyle habits, including intake of artificially sweetened beverages, by question­naire four months into chemother­apy treatment and six months after completing therapy. The findings of a benefit associated with artificial­ly sweetened beverages persisted even after researchers adjusted for factors that could affect the results, such as body mass index, physical activity, following Western eating patterns and dietary glycemic load, they wrote. Glycemic load refers to the amount a particular food raises the glucose level in a person’s blood; sugars and other carbohydrates tend to increase this number.

The scientists suggested that consumption of both categories of beverages should also be studied in people who have not developed colon cancer.

“Given the likelihood that individuals who consume artificially sweetened beverages following cancer diagnosis also consumed artificially sweetened beverages prior to cancer diagnosis, we can­not exclude the possibility that individuals who consume artificially sweetened beverages develop biologically less aggressive colon cancer tumors,” they wrote. “Future studies should examine artifi­cially sweetened beverage intake both before and after colon can­cer diagnosis in order to further elucidate the relationship between artificially sweetened beverage intake and colon cancer recurrence and mortality.”

Diet soda’s affect on initial colon cancer risk should be studied next, scientists say.

Articles in this issue

Positively Deleterious
Tutu Good
Paying it Forward: Donating Time in the Cancer Community
Hockey Player Announces His Cancer Is In Remission
Ginsburg Returns to Work During Recovery From Lung Surgery
Findings Link Diet Soda With Reduced Risk of Colon Cancer Recurrence

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of colorectal cancer
Photo of Dr. Usman Shah
An off-the-shelf cancer vaccine is associated with durable responses and a reduced risk of relapse and death among patients with pancreatic or colorectal cancers.
Related Content
Advertisement
Photo of Tania Chomiak-Salvi
September 15th 2025

Perioperative Immunotherapy ‘Is The Revolution’ in NSCLC

Alex Biese
Dr. Dawn Mussallem in a bright yellow shirt and pink hat, both with breast cancer ribbons on it, showing off her medal at the finish line of The DONNA Foundaton marathon | Photo credit: The DONNA Foundation
September 15th 2025

Doctor, Cancer Survivor and Marathoner Goes the Distance for Her Patients: ‘Now I Can Just Give’

Alex Biese
Photo of Dr. Joshua K. Sabari
September 15th 2025

Perioperative Therapy in Resectable NSCLC: The Drive for a Cure

Dr. Joshua K. Sabari
Teri Greige with medals
September 15th 2025

The Sport of Cancer: How One Survivor Linked Ironman Training and Colorectal Cancer

Brielle Benyon
Image of FDA offices
September 15th 2025

FDA Grants Designations for D3S-001 in KRAS G12C-Mutated Cancers

Ryan Scott
The FDA granted breakthrough device designation to an MRD test for patients with stage 2 colorectal cancer: © stock.adobe.com.
September 15th 2025

FDA Grants Breakthrough Device Status to MRD Test in Colorectal Cancer

Alex Biese
Related Content
Advertisement
Photo of Tania Chomiak-Salvi
September 15th 2025

Perioperative Immunotherapy ‘Is The Revolution’ in NSCLC

Alex Biese
Dr. Dawn Mussallem in a bright yellow shirt and pink hat, both with breast cancer ribbons on it, showing off her medal at the finish line of The DONNA Foundaton marathon | Photo credit: The DONNA Foundation
September 15th 2025

Doctor, Cancer Survivor and Marathoner Goes the Distance for Her Patients: ‘Now I Can Just Give’

Alex Biese
Photo of Dr. Joshua K. Sabari
September 15th 2025

Perioperative Therapy in Resectable NSCLC: The Drive for a Cure

Dr. Joshua K. Sabari
Teri Greige with medals
September 15th 2025

The Sport of Cancer: How One Survivor Linked Ironman Training and Colorectal Cancer

Brielle Benyon
Image of FDA offices
September 15th 2025

FDA Grants Designations for D3S-001 in KRAS G12C-Mutated Cancers

Ryan Scott
The FDA granted breakthrough device designation to an MRD test for patients with stage 2 colorectal cancer: © stock.adobe.com.
September 15th 2025

FDA Grants Breakthrough Device Status to MRD Test in Colorectal Cancer

Alex Biese
About Us
Advertise / Support
Editorial Board
Contact Us
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.